ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Zerenex Molecular Limited

Zerenex Molecular Limited is an active company incorporated on 31 May 2006 with the registered office located in Bolton, Greater Manchester. Zerenex Molecular Limited was registered 19 years ago.
Status
Active
Active since incorporation
Company No
05832688
Private limited company
Age
19 years
Incorporated 31 May 2006
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 31 May 2025 (5 months ago)
Next confirmation dated 31 May 2026
Due by 14 June 2026 (7 months remaining)
Last change occurred 8 years ago
Accounts
Due Soon
For period 1 Mar ⟶ 29 Feb 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 28 February 2025
Due by 30 November 2025 (28 days remaining)
Learn more about Zerenex Molecular Limited
Contact Update Details
Address
32 Westland Avenue
Bolton
Lancashire
BL1 5NP
Same address for the past 14 years
Telephone
01204527700
Email
Available in Endole App
See All Contacts
People
Officers
2
Shareholders
2
Controllers (PSC)
1
Dr Mohamed Hanif Bhatia
Director • PSC • British • Lives in UK • Born in Mar 1974
Hamna Ismailjee
Director • Manager • British • Lives in England • Born in Nov 1984
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Arza Bioscience Limited
Dr Mohamed Hanif Bhatia and Hamna Ismailjee are mutual people.
Active
Zylexa Pharma Ltd
Hamna Ismailjee is a mutual person.
Active
Fenton Studios Limited
Dr Mohamed Hanif Bhatia is a mutual person.
Active
Aqura Bioscience Ltd
Hamna Ismailjee is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
29 Feb 2024
For period 1 Mar ⟶ 29 Feb 2024
Traded for 12 months
Cash in Bank
£12.19K
Decreased by £27.16K (-69%)
Turnover
Unreported
Same as previous period
Employees
3
Same as previous period
Total Assets
£334.46K
Decreased by £79.4K (-19%)
Total Liabilities
-£341.34K
Decreased by £8.19K (-2%)
Net Assets
-£6.88K
Decreased by £71.21K (-111%)
Debt Ratio (%)
102%
Increased by 17.6% (+21%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
4 Months Ago on 19 Jun 2025
Full Accounts Submitted
11 Months Ago on 30 Nov 2024
Confirmation Submitted
1 Year 4 Months Ago on 24 Jun 2024
Full Accounts Submitted
1 Year 11 Months Ago on 30 Nov 2023
Confirmation Submitted
2 Years 4 Months Ago on 3 Jul 2023
Mrs Hamna Ismailjee Appointed
2 Years 11 Months Ago on 1 Dec 2022
Full Accounts Submitted
2 Years 11 Months Ago on 27 Nov 2022
Confirmation Submitted
3 Years Ago on 28 Jun 2022
Full Accounts Submitted
3 Years Ago on 25 Nov 2021
Confirmation Submitted
4 Years Ago on 1 Jul 2021
Get Alerts
Get Credit Report
Discover Zerenex Molecular Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 31 May 2025 with no updates
Submitted on 19 Jun 2025
Total exemption full accounts made up to 29 February 2024
Submitted on 30 Nov 2024
Confirmation statement made on 31 May 2024 with no updates
Submitted on 24 Jun 2024
Total exemption full accounts made up to 28 February 2023
Submitted on 30 Nov 2023
Confirmation statement made on 31 May 2023 with no updates
Submitted on 3 Jul 2023
Appointment of Mrs Hamna Ismailjee as a director on 1 December 2022
Submitted on 6 Dec 2022
Total exemption full accounts made up to 28 February 2022
Submitted on 27 Nov 2022
Confirmation statement made on 31 May 2022 with no updates
Submitted on 28 Jun 2022
Total exemption full accounts made up to 28 February 2021
Submitted on 25 Nov 2021
Confirmation statement made on 31 May 2021 with no updates
Submitted on 1 Jul 2021
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs